Abbott LaboratoriesABT

Where ABT's EV/EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$104.57+1.93 (+1.88%)Previous close
NYSEHealthcareDividend King

ABT EV/EBITDA: current value, 10-year range and year-by-year history

EV/EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
ABT EV/EBITDA historyABT EV/EBITDA from Oct 2023 to Sep 2026: low 15.3, high 23.3, latest 17.96.14.6616.9819.321.6223.95Oct 23May 24Dec 24Jul 25Mar 26Sep 26med 19.35

ABT EV/EBITDA by year

Yearly range of ABT’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 13.2 to 28.6, averaging 20.3.

ABT EV/EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202615.317.620.418.0
202518.420.523.319.4
202417.619.320.818.9
202315.018.020.920.0
202213.216.121.215.5
202117.621.626.921.4
202016.123.928.623.2
201919.421.923.721.5
201819.121.022.920.9
201719.122.325.520.2
201620.320.921.720.6

Get notified when ABT EV/EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.

Formula(Market Cap + Net Debt) / EBITDA
Full guide
How to read this chart

Unlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.

Key caveats
  • EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
  • Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.